$10.40 -0.60 (-5.46%) Stemline Therapeutics Inc - NASDAQ

Jan. 20, 2017 | 04:00 PM

Quotes

  1. Quotes

  2. Charts

  3. Analysis

  4. Options

  5. Historical



Last Trade: 10.40
Trade Time: Jan 20 04:00 PM Eastern Daylight Time
Change: -0.60 (-5.46%)
Prev Close: 11.00
Open: 10.40
Bid: 10.40
Ask: 10.45
  1. No results found.
  1. Stemline Therapeutics Prices $45 Million Public Offering of Common Stock

    GlobeNewswire | Jan. 20, 2017 | 09:00AM EST
  2. Morning Call For Friday, Jan. 20

    TalkMarkets | Jan. 20, 2017 | 08:16AM EST
  3. Stemline Therapeutics Announces Proposed Public Offering of Common Stock

    GlobeNewswire | Jan. 19, 2017 | 16:03PM EST
  4. Stemline Therapeutics Presents Clinical Update From Ongoing SL-401 Pivotal BPDCN Trial, Produced 86% Overall Response Rate

    Benzinga | Dec. 7, 2015 | 11:24AM EST
  5. Stemline Reports Five Presentations, Will Offer Update on SL-401 Trial from Ongoing Pivotal BPDCN Trial at ASH Meeting

    Benzinga | Dec. 4, 2015 | 08:02AM EST
  6. Stemline Therapeutics Offers Top-Line Results from Lead-In Stage of Ongoing BPDCN Pivotal Trial: Says SL-401 Showed Multi-Cycle Safety, Efficacy

    Benzinga | May. 28, 2015 | 15:16PM EST
  7. Biotech Stocks Moving Higher

    Benzinga | Feb. 23, 2015 | 15:35PM EST
  8. Wedbush Weighs in on Medivation Following Phase II TERRAIN Study Results

    GuruFocus | Feb. 3, 2015 | 12:50PM EST
  9. Biotechs Presenting At The J.P. Morgan Healthcare Conference: Day 4

    Benzinga | Jan. 13, 2015 | 11:34AM EST
  10. Mid-Morning Market Update: Markets Jump; Family Dollar Profit Misses Estimates

    Benzinga | Jan. 8, 2015 | 11:39AM EST
  11. Morning Market Losers

    Benzinga | Jan. 8, 2015 | 09:54AM EST
  12. Events Scheduled for Week of Jun. 16th to Jun. 20th

    Benzinga | Jun. 17, 2014 | 09:48AM EST
  13. US Stock Futures Drop; Alcoa Earnings In Focus

    Benzinga | Apr. 8, 2014 | 06:25AM EST
  14. Stemline Therapeutics Announces FDA Acceptance of IND for SL-701

    Benzinga | Apr. 8, 2014 | 06:02AM EST
  15. Stemline Therapeutics Present Clinical Trial Results of Synthetic Peptide Vaccine for Brain Cancer at SNO Annual Meeting

    Benzinga | Nov. 23, 2013 | 08:50AM EST
Trading Center